CG Oncology (NASDAQ:CGON) Stock Rating Lowered by Wall Street Zen

CG Oncology (NASDAQ:CGON – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued on Saturday. A number of other analysts also recently commented on the company. Scotiabank initiated coverage on CG Oncology in a research report on Wednesday, April […]

Leave a Reply

Your email address will not be published.

Previous post Maplebear (NASDAQ:CART) Raised to “Buy” at Wall Street Zen
Next post Wall Street Zen Downgrades DeFi Development (NASDAQ:DFDV) to Sell